Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nemolizumab | 0.65 | 0.6 | 2792 | 86 | 11 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nemolizumab | 0.6 | 1 | 4031 | 33 |
nemolizumab galderma | 0.3 | 0.7 | 1903 | 2 |
nemolizumab brand name | 0.52 | 0.8 | 7960 | 51 |
nemolizumab atopic dermatitis | 1.56 | 0.4 | 9689 | 73 |
nemolizumab prurigo nodularis | 1.96 | 0.4 | 5745 | 70 |
nemolizumab fda approval | 0.03 | 0.6 | 1444 | 19 |
nemolizumab fda | 0.93 | 0.9 | 6503 | 77 |
nemolizumab phase 3 | 0.92 | 0.3 | 5861 | 9 |
nemolizumab ema | 0.11 | 1 | 255 | 96 |
nemolizumab approval | 0.36 | 0.5 | 493 | 12 |
nemolizumab pronounce | 1.82 | 0.2 | 5771 | 71 |
nemolizumab side effects | 1.49 | 0.3 | 7915 | 89 |
nemolizumab zulassung | 1.42 | 0.8 | 4089 | 47 |
nemolizumab adolescent dosage | 0.82 | 0.9 | 5312 | 6 |
nemolizumab atopic dermatitis phase 3 | 1.43 | 1 | 4688 | 40 |